"The majority of adults experienced some kind of gastrointestinal problem in the last year, and just over half treated their ailment with an OTC (over-the-counter) medication. This denotes a strong base of digestive health consumers for category players. Still, category sales went relatively unchanged from 2016-17 as sales softened in the leading antacid segment. Increased interest and acceptance of proactive digestive health care could provide a needed boost in the ...
Download:
Search within report
Searching...
Overview
Overview
This report provides in-depth analysis and insight supported by a range of data. At the same time, introductory and top-level content is provided to give you an overview of the issues covered.
Overview
Executive Summary
Market
Market
Mintel provides a range of market information, frequently through the category level, including market size and forecasting, complete with market drivers that illustrate the forces that shape a category or market.
The Market – What You Need to Know
Market Size and Forecast
Market Breakdown
Market Perspective
Market Factors
Consumer
Consumer
Mintel's proprietary consumer research provides our analysts with the attitudinal and behavioral data used to provide valuable insight to topical issues.
The Consumer – What You Need to Know
Ailments and Treatment
Digestive Health Frequency Self-assessment
Digestive Health Level of Discomfort Self-assessment
Barriers to Treatment
OTC Selection Factors
Perceptions of OTC Remedies
Proactive Care
Brand/Company
Brand/Company
Mintel provides overviews of the top brands and manufacturers, and uses consumer research to explore attitudes and reactions to brands, as well as insight into what will resonate with consumers.
Key Players – What You Need to Know
Manufacturer Sales of Digestive Health Remedies
What’s Working?
What’s Struggling?
What’s Next?
Data
Data
Reports provide appendices of data to support the research and insight produced. Our tables of data are easily manipulated and downloadable to support your research needs and covers factors from consumer attitudes to market forecasts.
Appendix – Data Sources and Abbreviations
Appendix – The Market
Appendix – Key Players
30th April 2018
“The FDA’s (US Food and Drug Administration) Commissioner requested major online retailers to limit the sale of an OTC (over-the-counter) anti-diarrheal which can mimic an opioid high when taken in very high doses.” 
6th December 2017
“AstraZeneca launched Nexium 24HR ClearMinis, a mini capsule version of Nexium 24HR.”
|
Widespread use and population growth offer stability; declines in antacids stifle performance
